ES2914357T3 - Nueva línea celular y usos de la misma - Google Patents
Nueva línea celular y usos de la misma Download PDFInfo
- Publication number
- ES2914357T3 ES2914357T3 ES18781992T ES18781992T ES2914357T3 ES 2914357 T3 ES2914357 T3 ES 2914357T3 ES 18781992 T ES18781992 T ES 18781992T ES 18781992 T ES18781992 T ES 18781992T ES 2914357 T3 ES2914357 T3 ES 2914357T3
- Authority
- ES
- Spain
- Prior art keywords
- cell line
- new cell
- myeloid leukemia
- cell under
- under atcc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000025113 myeloid leukemia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
- C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Peptides Or Proteins (AREA)
- Error Detection And Correction (AREA)
Abstract
Una célula de leucemia mieloide de tipo dendrítico no natural según la designación de depósito de patente de la ATCC PTA-123875.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1715445.1A GB201715445D0 (en) | 2017-09-25 | 2017-09-25 | Novel cell line and uses thereof |
PCT/EP2018/075829 WO2019057977A1 (en) | 2017-09-25 | 2018-09-24 | NEW CELL LINE AND ASSOCIATED USES |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2914357T3 true ES2914357T3 (es) | 2022-06-09 |
Family
ID=60244513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES18781992T Active ES2914357T3 (es) | 2017-09-25 | 2018-09-24 | Nueva línea celular y usos de la misma |
Country Status (14)
Country | Link |
---|---|
US (1) | US11815509B2 (es) |
EP (1) | EP3688145B1 (es) |
JP (1) | JP7356415B2 (es) |
KR (1) | KR20200057013A (es) |
CN (1) | CN111295441B (es) |
AU (1) | AU2018335382A1 (es) |
BR (1) | BR112020005897A2 (es) |
CA (1) | CA3074791A1 (es) |
DK (1) | DK3688145T3 (es) |
ES (1) | ES2914357T3 (es) |
GB (1) | GB201715445D0 (es) |
IL (1) | IL273247A (es) |
TW (1) | TWI804508B (es) |
WO (1) | WO2019057977A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201700138D0 (en) | 2017-01-05 | 2017-02-22 | Senzagen Ab | Analytical methods and arrays for use in the same |
CN114672460B (zh) * | 2021-12-21 | 2023-06-23 | 中国人民解放军军事科学院军事医学研究院 | 一种靶向cd44的异质型cic细胞模型的制备方法及应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
AU2008337465A1 (en) | 2007-12-18 | 2009-06-25 | Biovator Technologies Ab | Improved assay |
GB201018014D0 (en) * | 2010-10-26 | 2010-12-08 | Senzagen Ab | Analytical methods and arrays for use in the same |
GB201207297D0 (en) * | 2012-04-26 | 2012-06-06 | Senzagen Ab | Analytical methods and arrays for use in the same |
GB201300049D0 (en) * | 2013-01-03 | 2013-02-20 | Transimmune Ag | Method for obtaining immuno-stimulatory dendritic cells |
GB201421207D0 (en) | 2014-11-28 | 2015-01-14 | Senzagen Ab | Analytical methods and arrays for use in the same |
DK3417074T3 (da) | 2016-03-23 | 2019-09-16 | Senzagen Ab | Analytiske fremgangsmåder og arrays til bestemmelse af den hudsensibiliserende virkning af midler in vitro |
-
2017
- 2017-09-25 GB GBGB1715445.1A patent/GB201715445D0/en not_active Ceased
-
2018
- 2018-09-13 TW TW107132270A patent/TWI804508B/zh active
- 2018-09-24 CA CA3074791A patent/CA3074791A1/en active Pending
- 2018-09-24 JP JP2020515726A patent/JP7356415B2/ja active Active
- 2018-09-24 ES ES18781992T patent/ES2914357T3/es active Active
- 2018-09-24 US US16/644,808 patent/US11815509B2/en active Active
- 2018-09-24 EP EP18781992.5A patent/EP3688145B1/en active Active
- 2018-09-24 DK DK18781992.5T patent/DK3688145T3/da active
- 2018-09-24 CN CN201880062208.2A patent/CN111295441B/zh active Active
- 2018-09-24 BR BR112020005897-1A patent/BR112020005897A2/pt unknown
- 2018-09-24 AU AU2018335382A patent/AU2018335382A1/en active Pending
- 2018-09-24 KR KR1020207009603A patent/KR20200057013A/ko not_active Application Discontinuation
- 2018-09-24 WO PCT/EP2018/075829 patent/WO2019057977A1/en unknown
-
2020
- 2020-03-11 IL IL273247A patent/IL273247A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2018335382A1 (en) | 2020-04-02 |
JP2020534825A (ja) | 2020-12-03 |
IL273247A (en) | 2020-04-30 |
US11815509B2 (en) | 2023-11-14 |
JP7356415B2 (ja) | 2023-10-04 |
BR112020005897A2 (pt) | 2020-09-29 |
KR20200057013A (ko) | 2020-05-25 |
WO2019057977A1 (en) | 2019-03-28 |
EP3688145A1 (en) | 2020-08-05 |
US20220178913A1 (en) | 2022-06-09 |
CA3074791A1 (en) | 2019-03-28 |
GB201715445D0 (en) | 2017-11-08 |
DK3688145T3 (en) | 2022-03-14 |
CN111295441B (zh) | 2024-03-26 |
CN111295441A (zh) | 2020-06-16 |
TWI804508B (zh) | 2023-06-11 |
TW201920660A (zh) | 2019-06-01 |
EP3688145B1 (en) | 2022-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2019001980A2 (es) | Anticuerpos anti-tigit, anticuerpos anti-pvrig y combinaciones de estos | |
MX2019007750A (es) | Moléculas guía sintéticas, composiciones y métodos relacionados con éstas. | |
MX2019007021A (es) | Anticuerpos il-11ra. | |
MX2021000027A (es) | Anticuerpos anti-factor de la coagulacion xi. | |
MX2017007629A (es) | Compuestos inhibidores de bcl-xl que tienen una baja permeabilidad en las celulas y conjugados de anticuerpo-farmaco que los incluyen. | |
MX2020002885A (es) | Derivados de galnac. | |
PH12018502586A1 (en) | Anti-coagulation factor xi antibodies | |
EA201791421A1 (ru) | Антитела против csf1r для лечения pvns | |
MX2018009325A (es) | Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn). | |
CA185542S (en) | Table | |
PH12021550102A1 (en) | Cardiosafe antidiabetic therapy | |
MX2018005785A (es) | Conjugados de anticuerpo anti-cd22-maytansina y metodos de uso de los mismos. | |
SG11202006252YA (en) | Hyper-branched compounds, synthesis and uses thereof | |
MX2018002416A (es) | Derivados de 1,7-diaril-1,6-heptadien-3,5-diona, procedimiento para la preparación y uso de los mismos. | |
ES2914357T3 (es) | Nueva línea celular y usos de la misma | |
MX2021014949A (es) | Recubrimientos resistentes a la incrustación biológica y métodos para elaborar y usar los mismos. | |
UY38309A (es) | Receptores químericos de steap1 y métodos de uso de los mismos | |
DOS2015000229S (es) | Sujecion para el cabello/brazalete | |
CL2016003102A1 (es) | 1h-1,8-naftiridin-2-onas como compuestos antiproliferativos. | |
CL2019000572A1 (es) | Compuesto de imida y uso del mismo. | |
IL276476A (en) | Certain chemical entities, compositions and methods | |
CL2019000808S1 (es) | Cabezal de cepillo de dientes. | |
CL2019000807S1 (es) | Cabezal de cepillo de dientes. | |
CL2019000806S1 (es) | Cabezal de cepillo de dientes. | |
MX2020005948A (es) | Complejos de zinc-aminoacido-tripolifosfato. |